Li-Jing Ma1, Ling-Li Xu1, Cheng-Jie Mao1, Yun-Ting Fu1, Xiao-Yan Ji2, Yun Shen1, Jing Chen1, Ya-Ping Yang1,3, Chun-Feng Liu1,3,4. 1. Department of Neurology and Suzhou Clinical Research Center of Neurological Disease, The Second Affiliated Hospital of Soochow University, Suzhou, China. 2. Department of Ophthalmology, The Second Affiliated Hospital of Soochow University, Suzhou, China. 3. Jiangsu Key Laboratory of Neuropsychiatric Diseases and Institute of Neuroscience, Soochow University, Suzhou, Jiangsu, China. 4. Parkinson Disease Center of Beijing Institute for Brain Disorders, Beijing, China.
Abstract
BACKGROUND: Many optical coherence tomography (OCT) studies have reported alterations in the retinal nerve fiber layer (RNFL) in Parkinson's disease (PD) and other neurodegenerative diseases. However, whether retinal alterations are a biomarker for PD is still controversial. OBJECTIVE: To investigate potential correlations between PD and morphological changes in retina using OCT and to determine its usefulness as a biomarker of disease progression in PD. METHODS: We performed a cross-sectional study on patients with PD (N = 37) and age-matched controls (N = 42), followed by a longitudinal study of the PD patients (N = 22) over approximately 2.5 years. RESULTS: The average retinal nerve fiber layer (RNFL) thickness (p < 0.001), total macular thickness (p = 0.001), and macular volume (p = 0.001) were decreased in PD patients compared to controls and had further decreased at the follow-up visit (p < 0.05 for all). The average RNFL thickness and the total thickness of macular were negatively correlated with age in PD patients at baseline. Linear regression analysis revealed that age (p = 0.002, p = 0.003, respectively) and LEDD (p = 0.011, p = 0.013, respectively) were correlated to total thickness and volume of macular in 22 PD patients in the follow-up study. However, no correlation was found between RNFL and other parameters. CONCLUSIONS: PD progression is associated with pronounced retinal structure changes, which can be quantified by OCT. Patterns of RNFL and macular damage detected by the noninvasive technology of OCT can be a useful biomarker for evaluating the progression of PD.
BACKGROUND: Many optical coherence tomography (OCT) studies have reported alterations in the retinal nerve fiber layer (RNFL) in Parkinson's disease (PD) and other neurodegenerative diseases. However, whether retinal alterations are a biomarker for PD is still controversial. OBJECTIVE: To investigate potential correlations between PD and morphological changes in retina using OCT and to determine its usefulness as a biomarker of disease progression in PD. METHODS: We performed a cross-sectional study on patients with PD (N = 37) and age-matched controls (N = 42), followed by a longitudinal study of the PDpatients (N = 22) over approximately 2.5 years. RESULTS: The average retinal nerve fiber layer (RNFL) thickness (p < 0.001), total macular thickness (p = 0.001), and macular volume (p = 0.001) were decreased in PDpatients compared to controls and had further decreased at the follow-up visit (p < 0.05 for all). The average RNFL thickness and the total thickness of macular were negatively correlated with age in PDpatients at baseline. Linear regression analysis revealed that age (p = 0.002, p = 0.003, respectively) and LEDD (p = 0.011, p = 0.013, respectively) were correlated to total thickness and volume of macular in 22 PDpatients in the follow-up study. However, no correlation was found between RNFL and other parameters. CONCLUSIONS:PD progression is associated with pronounced retinal structure changes, which can be quantified by OCT. Patterns of RNFL and macular damage detected by the noninvasive technology of OCT can be a useful biomarker for evaluating the progression of PD.
Authors: Hannah Currant; Pirro Hysi; Tomas W Fitzgerald; Puya Gharahkhani; Pieter W M Bonnemaijer; Anne Senabouth; Alex W Hewitt; Denize Atan; Tin Aung; Jason Charng; Hélène Choquet; Jamie Craig; Peng T Khaw; Caroline C W Klaver; Michiaki Kubo; Jue-Sheng Ong; Louis R Pasquale; Charles A Reisman; Maciej Daniszewski; Joseph E Powell; Alice Pébay; Mark J Simcoe; Alberta A H J Thiadens; Cornelia M van Duijn; Seyhan Yazar; Eric Jorgenson; Stuart MacGregor; Chris J Hammond; David A Mackey; Janey L Wiggs; Paul J Foster; Praveen J Patel; Ewan Birney; Anthony P Khawaja Journal: PLoS Genet Date: 2021-05-12 Impact factor: 5.917
Authors: Ane Murueta-Goyena; Rocío Del Pino; Marta Galdós; Begoña Arana; Marian Acera; Mar Carmona-Abellán; Tamara Fernández-Valle; Beatriz Tijero; Olaia Lucas-Jiménez; Natalia Ojeda; Naroa Ibarretxe-Bilbao; Javier Peña; Jesus Cortes; Unai Ayala; Maitane Barrenechea; Juan Carlos Gómez-Esteban; Iñigo Gabilondo Journal: Ann Neurol Date: 2020-11-09 Impact factor: 10.422
Authors: Diego Santos García; Lucía Naya Ríos; Teresa de Deus Fonticoba; Carlos Cores Bartolomé; Lucía García Roca; Maria Feal Painceiras; Cristina Martínez Miró; Hector Canfield; Silvia Jesús; Miquel Aguilar; Pau Pastor; Marina Cosgaya; Juan García Caldentey; Nuria Caballol; Inés Legarda; Jorge Hernández Vara; Iria Cabo; Lydia López Manzanares; Isabel González Aramburu; María A Ávila Rivera; Víctor Gómez Mayordomo; Víctor Nogueira; Víctor Puente; Julio Dotor; Carmen Borrué; Berta Solano Vila; María Álvarez Sauco; Lydia Vela; Sonia Escalante; Esther Cubo; Francisco Carrillo Padilla; Juan C Martínez Castrillo; Pilar Sánchez Alonso; Maria G Alonso Losada; Nuria López Ariztegui; Itziar Gastón; Jaime Kulisevsky; Marta Blázquez Estrada; Manuel Seijo; Javier Rúiz Martínez; Caridad Valero; Mónica Kurtis; Oriol de Fábregues; Jessica González Ardura; Ruben Alonso Redondo; Carlos Ordás; Luis M López Díaz; Darrian McAfee; Pablo Martinez-Martin; Pablo Mir Journal: Diagnostics (Basel) Date: 2021-12-17